Literature DB >> 11684557

Iron deposition in renal biopsy specimens from patients with kidney diseases.

H Wang1, K Nishiya, H Ito, T Hosokawa, K Hashimoto, T Moriki.   

Abstract

This study was performed to investigate the correlation between clinical parameters and grading of iron deposition in renal biopsy specimens from 102 patients with various kidney diseases. Iron deposition in renal tissues was detected by Berlin blue staining. The extent of iron staining was semiquantitatively graded as negative (Fe(-)), grade 0, or positive (Fe(+)), including faint, grade 1; moderate, grade 2; or severe, grade 3, by light microscopy. Thirty-four of 102 patients (33%) showed positive iron staining. Fe(+) patients had various renal diseases, mainly consisting of 12 patients with immunoglobulin A nephropathy and 5 patients with benign nephrosclerosis. Mean arterial pressure (MAP), serum creatinine (sCr) levels, incidence of hematuria, and urinary N-acetylbeta-D-glucosaminidase (u-NAG) levels in Fe(+) patients were significantly greater than those in Fe(-) patients, and u-NAG levels correlated positively with the extent of iron deposition. Study patients were tentatively divided into two groups according to the extent of iron deposition: group A, patients with grades 2 and 3 staining, and group B, patients with grades 0 and 1 staining. In group A, MAP, sCr level, urinary protein excretion, and the incidence of hematuria were significantly greater than in group B. Our results suggest that the amount of iron deposition in renal tissue may contribute to the progression of chronic renal disease and may be an early and sensitive indicator of renal damage in certain renal diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684557     DOI: 10.1053/ajkd.2001.28593

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  21 in total

Review 1.  NGAL-Siderocalin in kidney disease.

Authors:  Neal Paragas; Andong Qiu; Maria Hollmen; Thomas L Nickolas; Prasad Devarajan; Jonathan Barasch
Journal:  Biochim Biophys Acta       Date:  2012-06-19

Review 2.  Overview of iron metabolism in health and disease.

Authors:  Som Dev; Jodie L Babitt
Journal:  Hemodial Int       Date:  2017-03-15       Impact factor: 1.812

3.  Acute and Chronic Iron Overloading Differentially Modulates the Expression of Cellular Iron-homeostatic Molecules in Normal Rat Kidney.

Authors:  Bassem Refaat; Abdelghany Hassan Abdelghany; Mohammad A BaSalamah; Mohamed El-Boshy; Jawwad Ahmad; Shakir Idris
Journal:  J Histochem Cytochem       Date:  2018-06-06       Impact factor: 2.479

4.  Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

5.  Effect of high density lipoprotein cholesterol on the relationship of serum iron and hemoglobin with kidney function in diabetes.

Authors:  Ashley N Williams; Baqiyyah N Conway
Journal:  J Diabetes Complications       Date:  2017-03-29       Impact factor: 2.852

6.  Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.

Authors:  James A Votava; Shannon R Reese; Kathryn M Deck; Christopher P Nizzi; Sheila A Anderson; Arjang Djamali; Richard S Eisenstein
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-29

Review 7.  Iron metabolism in the pathogenesis of iron-induced kidney injury.

Authors:  A M F Martines; R Masereeuw; H Tjalsma; J G Hoenderop; J F M Wetzels; D W Swinkels
Journal:  Nat Rev Nephrol       Date:  2013-05-14       Impact factor: 28.314

Review 8.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

9.  Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Behjat Alsaadat Moaeidi; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Hamid Nasri; Shahrzad Baradaran; Marjan Gharagozloo; Tahereh Safari; Maryam Haghighi
Journal:  Int J Prev Med       Date:  2013-03

10.  A Rare Cause of Reversible Renal Hemosiderosis.

Authors:  Rima Abou Arkoub; Don Wang; Deborah Zimmerman
Journal:  Case Rep Nephrol       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.